Table 1. Clinical and genetic features of the Fabry patients.

Patient no.	Age at inclusion	Sex	Mutation	Cerebro-vascular disease before inclusion	Cerebro-vascular disease during study	Cardio-vascular disease before inclusion	Cardio-vascular disease during study	Renal event before inclusion	Renal event during study	ERT
1	36	M	R342X	-	-	-	-	-	-	+
2	10	M	G85D	-	-	-	-	-	-	+
3	60	F	A156T	+	-	U	+	-	-	+
4	37	M	A156T	+	-	-	+	D	KT	+
5	63	F	A156T	-	-	+	-	-	-	+
6	58	F	A156T	+	-	+	+	-	-	+
7	41	F	A156T	-	-	-	+	-	-	+
8	38	F	G85D	-	-	-	-	-	-	+
9	42	F	A156T	-	+	-	-	-	-	+
10	37	M	A156T	-	-	-	-	-	-	+
11	15	M	N34S	-	-	-	-	-	-	+
12	15	F	A156T	-	-	-	-	-	-	+
13	33	F	A156T	-	-	+	-	-	-	-
14	27	F	G85D	+	-	-	-	-	-	+
15	34	F	N34S	+	-	-	-	-	-	+
16	54	F	A156T	-	-	+	-	-	-	+
17	34	M	G85D	-	-	-	-	-	-	+
18	18	M	N34S	-	-	-	-	-	-	+
19	59	F	G85D	+	-	-	+	-	-	+
20	48	F	N34S	-	-	+	-	-	-	+
21	55	F	G85D	-	-	-	+	-	-	+
22	35	M	G85D	-	-	-	-	-	D, KT	+
23	24	M	N34S	-	-	-	-	-	-	+
24	58	F	G85D	+	-	+	-	-	-	+
25	58	F	G85D	-	+	-	-	-	-	+
26	26	M	G85D	-	-	-	-	-	-	+
27	39	F	G85D	-	-	-	-	-	-	-
28	33	F	G85D	-	-	-	-	-	-	+
29	18	F	c.369+3_c.547	-	-	-	-	-	-	+
30	50	F	G10694	-	-	-	-	-	-	+
31	47	M	G10694	-	-	-	-	-	-	+
32	40	F	G85D	-	-	-	-	-	-	+
33	66	F	G271S	+	-	+	-	-	-	+
34	29	M	G85D	-	-	-	-	D, KT	-	-
35	35	M	N34S	-	-	-	-	-	-	-
36	44	F	D313Y	-	-	-	-	-	-	-
37	39	F	G271S + D313Y	-	-	-	-	-	-	- *
38	40	F	A156T	-	-	-	-	-	-	-
39	64	F	I232T	-	-	-	-	-	-	-
40	36	M	I232T	-	-	-	-	-	-	+

“+” yes

“-”no

*Chaparone-therapy.

ERT: Enzyme replacement treatment

Cerebrovascular disease: Infarct or hemorrhage

Cardiovascular disease: Arrhythmia, congestive heart failure or myocardial infarction

Renal event: Dialysis (D) or kidney transplantation (KT)

Unknown: U